KIT-exon-9-mutated GISTs tend to have a more aggressive clinical course than KIT-exon-11-mutated GISTs, whereas patients with PDGFRA-mutated GIST usually have a favorable prognosis and seldom give rise to metastases [8]. This evidence concerns the gene KIT and gastrointestinal stromal tumor.